Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-COV-2: Case report with autopsy review

被引:7
|
作者
Taweevisit, Mana [1 ,2 ,3 ,8 ]
Chindamporn, Ariya [2 ,3 ,4 ]
Sujjavorakul, Kritsaporn [3 ,5 ,6 ]
Samransamruajkit, Rujipat [2 ,6 ]
Thorner, Paul Scott [1 ,7 ]
机构
[1] Chulalongkorn Univ, Fac Med, Dept Pathol, Bangkok 10330, Thailand
[2] King Chulalongkorn Mem Hosp, Bangkok 10330, Thailand
[3] Thai Red Cross Soc, Bangkok 10330, Thailand
[4] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok 10330, Thailand
[5] King Chulalongkorn Mem Hosp, Crit Care Excellence Ctr, Bangkok 10330, Thailand
[6] Chulalongkorn Univ, Fac Med, Dept Pediat, Bangkok 10330, Thailand
[7] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON 518, Canada
[8] Chulalongkorn Univ, Fac Med, Dept Pathol, 1873 King Rama 4Street, Bangkok 10330, Thailand
关键词
COVID-19; SARS-COV-2; MIS-C; Aspergillosis; Cytomegalovirus; Cardiomyopathy; COVID-19;
D O I
10.1016/j.prp.2022.154106
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Multisystem inflammatory syndrome in children (MIS-C) is an emerging phenomenon associated with SARS-COV-2 infection (COVID-19) occurring in < 1 % of infected children. MIS-C is characterized by a hyper -inflammatory state with excessive cytokine release ('storm') leading to hemodynamic compromise and multi -organ failure, with a death rate of similar to 2 %. Autopsy examination can play a particularly important role in helping to understand the pathogenesis of MIS-C. Yet, only five autopsy studies have been reported to date. We report a fatal case of MIS-C involving a previously healthy, 5-year-old Thai boy admitted with MIS-C, one month after exposure to SARS-COV-2. While in intensive care, he was found to have a hypertrophic cardiomyopathy, and despite immunosuppressive treatment for MIS-C, developed shock and died. Multiorgan inflammation was not found at autopsy, implying that the MIS-C had responded to treatment. However, there was disseminated aspergillosis and cytomegalovirus reactivation, attributed to the immunosuppression. SARS-COV-2 virus was also found in multiple organs. To the best of our knowledge, this is the first reported autopsy of an MIS-C patient from Asia, and the first report of aspergillosis in MIS-C. This case underscores that the risks of immunosuppression are also a concern in MIS-C. Although MIS-C is generally considered to be a post-infectious hyperimmune reaction, persistence of SARS-COV-2 is a feature in all autopsies of MIS-C patients reported to date, suggesting a possible role in the pathogenesis, at least in fatal cases.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Safety of SARS-CoV-2 vaccine in children with a history of Multisystem Inflammatory Syndrome (MIS-C)
    Herrera, Karina Saravia
    Jimenez, Josefa Hojman
    Bichara, Javier Troncoso
    Copiz, Giannina Izquierdo
    Morel, Cecilia Pinera
    Aranda, Paula Leal
    Martinez, Rodolfo Villena
    ANDES PEDIATRICA, 2024, 95 (06): : 703 - 710
  • [2] SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report from Iraq
    Al-Simaani, Ruwaid Behnam Y.
    Al-Kzayer, Lika'a Fasih Y.
    Ali, Kenan Hussien
    Al-Ani, Mouroge H.
    Nakazawa, Yozo
    PEDIATRIC REPORTS, 2023, 15 (03): : 532 - 540
  • [3] Case Series of Multisystem Inflammatory Syndrome (MIS-C) in Children during the SARS-CoV-2 Pandemic in Latvia
    Racko, Iveta
    Smane, Liene
    Klavina, Lizete
    Pucuka, Zanda
    Roge, Ieva
    Pavare, Jana
    CLINICS AND PRACTICE, 2021, 11 (02) : 363 - 373
  • [4] Detection of faecal SARS-CoV-2 RNA in a prospective cohort of children with multisystem inflammatory syndrome (MIS-C)
    Parodi, Emilia
    Carpino, Andrea
    Franchitti, Elena
    Pruccoli, Giulia
    Denina, Marco
    Pagliero, Federica
    Ramenghi, Ugo
    Traversi, Deborah
    EPIDEMIOLOGIA & PREVENZIONE, 2021, 45 (06): : 522 - 527
  • [5] Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection
    Ghodsi, Alireza
    Mahmoudabadi, Elnaz
    Ghahremani, Sara
    Malek, Abdolreza
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2021, 9 (04):
  • [6] Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)
    Kuypers, Frans A.
    Rostad, Christina A.
    Anderson, Evan J.
    Chahroudi, Ann
    Jaggi, Preeti
    Wrammert, Jens
    Mantus, Grace
    Basu, Rajit
    Harris, Frank
    Hanberry, Bradley
    Camacho-Gonzalez, Andres
    Manoranjithan, Shaminy
    Vos, Miriam
    Brown, Lou Ann
    Morris, Claudia R.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (23) : 2543 - 2552
  • [7] Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2
    Yeo, Wee Song
    Ng, Qin Xiang
    MEDICAL HYPOTHESES, 2020, 144
  • [8] Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
    Minoia, Francesca
    Lucioni, Federica
    Heshin-Bekenstein, Merav
    Vastert, Sebastiaan
    Kessel, Christoph
    Uziel, Yosef
    Lamot, Lovro
    Ruperto, Nicolino
    Gattorno, Marco
    Bracaglia, Claudia
    Toplak, Natasa
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [9] The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis
    Patel, Maitray A.
    Fraser, Douglas D.
    Daley, Mark
    Cepinskas, Gediminas
    Veraldi, Noemi
    Grazioli, Serge
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [10] Biomarker profile in pediatric inflammatory multisystem syndrome temporarily associated with SARS-CoV-2 (PIMS-TS)/multisystem inflammatory syndrome in children (MIS-C)
    Basu, Surupa
    Bhattacharyya, Arunaloke
    Ray, Kshounish
    Ghosh, Apurba
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2020, 57 (06) : 687 - 693